Literature DB >> 18651114

Fabrication of pre-determined shape of bone segment with collagen-hydroxyapatite scaffold and autogenous platelet-rich plasma.

Shih-Hsin Chang1, Yuan-Ming Hsu, Yng Jiin Wang, Yeou-Ping Tsao, Kwan-Yi Tung, Tao-Yuan Wang.   

Abstract

BACKGROUND: Reconstruction of large segment of bony defects is frequently needed in hand surgery. Autogenous bone grafting is considered the standard in management of these bony defects but has limited source of graft material. Collagen and hydroxyapatite have been used as bone-filling materials and are known to serve as the osteoconductive scaffold for bone regeneration. On the other hand, platelet-rich plasma is a kind of natural source of growth factors, and has been used successfully in bone regeneration and improving wound healing. This study was designed to evaluate the effectiveness of using biohybrids of platelet-rich plasma and collagen-hydroxyapatite beads for fabricating of protrusive bone in a rabbit animal model.
METHODS: Biomaterial beads comprised of particulate hydroxyapatite dispersed in fibrous collagen (type I) matrices were prepared and filled in the ringed polytetrafluoroethylene (PTFE) artificial vascular graft (3 cm long, 1 cm in diameter). New Zealand White rabbits were each implanted with two cylindrical PTFE artificial vascular graft over both iliac crests (n = 16). A 2 x 0.5 cm opening was created at the side of each PTFE chamber to allow the content of chamber in contact with the bone marrow of the ileum. The chambers were empty (groups A and D), filled with type I collagen/hydroxyapatite beads (groups B and C). In groups C and D, autologous platelet rich plasma (PRP) was given by transcutaneous injection method into the chambers every week. After 12 weeks, the animals were sacrificed and the chambers were harvested for radiological and histological analysis.
RESULTS: In plain radiographs, the group C chambers had significantly higher bone tissue engineered (average calcified density 0.95, average calcified area 61.83%) compared with other groups (P < 0.001). In histological examination, there was a creeping substitution of the implant by the in-growth of fibrovascular tissue in group C. Abundant fibrovascular networks positioned interstitially between these biomaterial beads in all parts of chamber. Degradation of these beads and newly formed capillaries and osteoids around the degraded matrixes are shown. The continually calcification in the matrixes or degraded matrixes is evidenced by the strong green fluorescence observed under the confocal microscope. In group B, looser architecture without evidence of tissue in-growth was shown. In the scaffold absent groups (A and D), there was only fibrous tissue shown within the chamber.
CONCLUSIONS: In this study, we have demonstrated a feasible approach to fabricate an osseous tissue that meets clinical need. Using the type I collagen/ hydroxyapatite gel beads matrixes and intermittent injection of autologous platelet-rich-plasma, specific 3D osseous tissues with fibrovascular network structure from pre-exist bony margin were successfully created in an in vivo animal model.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18651114     DOI: 10.1007/s10856-008-3507-1

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  29 in total

1.  Reconstruction of composite metacarpal defects using a fibula free flap.

Authors:  H B Lee; K C Tark; S Y Kang; S W Kim; Y K Chung
Journal:  Plast Reconstr Surg       Date:  2000-04       Impact factor: 4.730

2.  Autologous concentrated platelet-rich plasma (cPRP) for local application in bone regeneration.

Authors:  A Dugrillon; H Eichler; S Kern; H Klüter
Journal:  Int J Oral Maxillofac Surg       Date:  2002-12       Impact factor: 2.789

3.  Collagen scaffolds reinforced with biomimetic composite nano-sized carbonate-substituted hydroxyapatite crystals and shaped by rapid prototyping to contain internal microchannels.

Authors:  Eleftherios Sachlos; Duce Gotora; Jan T Czernuszka
Journal:  Tissue Eng       Date:  2006-09

4.  In vitro and in vivo studies with collagen/hydroxyapatite implants.

Authors:  H A Marouf; A A Quayle; P Sloan
Journal:  Int J Oral Maxillofac Implants       Date:  1990       Impact factor: 2.804

5.  Platelet-rich plasma: Growth factor enhancement for bone grafts.

Authors:  R E Marx; E R Carlson; R M Eichstaedt; S R Schimmele; J E Strauss; K R Georgeff
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  1998-06

Review 6.  Bone growth factors in maxillofacial skeletal reconstruction.

Authors:  H Schilephake
Journal:  Int J Oral Maxillofac Surg       Date:  2002-10       Impact factor: 2.789

Review 7.  Tissue engineering.

Authors:  R Langer; J P Vacanti
Journal:  Science       Date:  1993-05-14       Impact factor: 47.728

8.  Tissue-engineered composites of bone and cartilage for mandible condylar reconstruction.

Authors:  Y Weng; Y Cao; C A Silva; M P Vacanti; C A Vacanti
Journal:  J Oral Maxillofac Surg       Date:  2001-02       Impact factor: 1.895

9.  Bioabsorbable scaffolds for guided bone regeneration and generation.

Authors:  M Kellomäki; H Niiranen; K Puumanen; N Ashammakhi; T Waris; P Törmälä
Journal:  Biomaterials       Date:  2000-12       Impact factor: 12.479

Review 10.  Tissue engineering by cell transplantation using degradable polymer substrates.

Authors:  L G Cima; J P Vacanti; C Vacanti; D Ingber; D Mooney; R Langer
Journal:  J Biomech Eng       Date:  1991-05       Impact factor: 2.097

View more
  9 in total

1.  Histopathologic Evaluation of Hyaluronic Acid and Plasma-Rich Platelet Injection into Rabbit Vocal Cords: An Experimental Study.

Authors:  Selmin Karataylı Özgürsoy; Fatma Tunçkaşık; M Emin Tunçkaşık; Egemen Akıncıoğlu; Handan Doğan; Güçlü Kaan Beriat
Journal:  Turk Arch Otorhinolaryngol       Date:  2018-03-01

Review 2.  New and emerging strategies in platelet-rich plasma application in musculoskeletal regenerative procedures: general overview on still open questions and outlook.

Authors:  Francesca Salamanna; Francesca Veronesi; Melania Maglio; Elena Della Bella; Maria Sartori; Milena Fini
Journal:  Biomed Res Int       Date:  2015-05-05       Impact factor: 3.411

3.  The role of platelet gel in osteoarticular injuries of young and old patients.

Authors:  Claudia Rizzo; Roberta Vetro; Angelo Vetro; Roberto Mantia; Angelo Iovane; Marco Di Gesù; Sonya Vasto; Laura Di Noto; Giuseppina Mazzola; Calogero Caruso
Journal:  Immun Ageing       Date:  2014-12-02       Impact factor: 6.400

Review 4.  Application of platelet-rich plasma with stem cells in bone and periodontal tissue engineering.

Authors:  Gabriela Fernandes; Shuying Yang
Journal:  Bone Res       Date:  2016-12-13       Impact factor: 13.567

5.  Evaluation of the Possible Synergic Regenerative Effects of Platelet-Rich Plasma and Hydroxyapatite/Zirconia in the Rabbit Mandible Defect Model.

Authors:  Sheila Shahsavari-Pour; Ehsan Aliabadi; Mona Latifi; Nehle Zareifard; Mohammad Reza Namavar; Tahereh Talaei-Khozani
Journal:  Iran J Med Sci       Date:  2018-11

6.  Mesenchymal stem cells and three-dimensional-osteoconductive scaffold regenerate calvarial bone in critical size defects in swine.

Authors:  Zoe M Johnson; Yuan Yuan; Xiangjia Li; Tea Jashashvili; Michael Jamieson; Mark Urata; Yong Chen; Yang Chai
Journal:  Stem Cells Transl Med       Date:  2021-04-01       Impact factor: 6.940

7.  A novel hypothesis: the application of platelet-rich plasma can promote the clinical healing of white-white meniscal tears.

Authors:  Li-Cheng Wei; Shu-Guang Gao; Mai Xu; Wei Jiang; Jian Tian; Guang-Hua Lei
Journal:  Med Sci Monit       Date:  2012-08

Review 8.  Recent developments of functional scaffolds for craniomaxillofacial bone tissue engineering applications.

Authors:  Yukihiko Kinoshita; Hatsuhiko Maeda
Journal:  ScientificWorldJournal       Date:  2013-09-15

Review 9.  Platelet-rich plasma in bone regeneration: engineering the delivery for improved clinical efficacy.

Authors:  Isaac A Rodriguez; Emily A Growney Kalaf; Gary L Bowlin; Scott A Sell
Journal:  Biomed Res Int       Date:  2014-06-23       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.